Evidence map›Paper›PMID 37399393›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics.

Pragati V Prasad, Molly K Steele, Carrie Reed, Lauren Ancel Meyers, Zhanwei Du, Remy Pasco, Jorge A Alfaro-Murillo, Bryan Lewis, Srinivasan Venkatramanan, James Schlitt and 18 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Pragati V PrasadApplied Research and Modeling Team, Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, GA 30333.ORCID 0000-0001-5066-2852
Molly K SteeleApplied Research and Modeling Team, Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, GA 30333.
Carrie ReedApplied Research and Modeling Team, Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, GA 30333.
Lauren Ancel MeyersSection of Integrative Biology and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712.
Zhanwei DuSection of Integrative Biology and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712.ORCID 0000-0002-2020-767X
Remy PascoSection of Integrative Biology and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712.ORCID 0000-0002-9321-6876
Jorge A Alfaro-MurilloDepartment of Biostatistics & Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06510.
Bryan LewisBiocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.ORCID 0000-0003-0793-6082
Srinivasan VenkatramananBiocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.ORCID 0000-0002-0874-8692
James SchlittBiocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
Jiangzhuo ChenBiocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
Mark OrrBiocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
Mandy L WilsonBiocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.ORCID 0000-0002-4778-5744
Stephen EubankBiocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.ORCID 0000-0002-7177-309X
Lijing WangBiocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.ORCID 0000-0002-0836-9190
Matteo ChinazziLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA 02115.ORCID 0000-0002-5955-1929
Ana Pastore Y PionttiLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA 02115.
Jessica T DavisLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA 02115.
M Elizabeth HalloranFred Hutchinson Cancer Research Center, Seattle, WA 98109.ORCID 0000-0002-3127-1757
Ira LonginiDepartment of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32603.
Alessandro VespignaniLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA 02115.ORCID 0000-0003-3419-4205
Sen PeiDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032.ORCID 0000-0002-7072-2995
Marta GalantiDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032.ORCID 0000-0002-9060-1250
Sasikiran KandulaDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032.
Jeffrey ShamanDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032.ORCID 0000-0002-7216-7809
David J HawMedical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2AZ, United Kingdom.ORCID 0000-0002-9228-0542
Nimalan ArinaminpathyMedical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2AZ, United Kingdom.ORCID 0000-0001-9502-6876
Matthew BiggerstaffApplied Research and Modeling Team, Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, GA 30333.ORCID 0000-0001-5108-8311

Funding

Medical Research Council MR/R015600/1Medical Research Council MR/X020258/1
6 · The paper itself

Abstract

When an influenza pandemic emerges, temporary school closures and antiviral treatment may slow virus spread, reduce the overall disease burden, and provide time for vaccine development, distribution, and administration while keeping a larger portion of the general population infection free. The impact of such measures will depend on the transmissibility and severity of the virus and the timing and extent of their implementation. To provide robust assessments of layered pandemic intervention strategies, the Centers for Disease Control and Prevention (CDC) funded a network of academic groups to build a framework for the development and comparison of multiple pandemic influenza models. Research teams from Columbia University, Imperial College London/Princeton University, Northeastern University, the University of Texas at Austin/Yale University, and the University of Virginia independently modeled three prescribed sets of pandemic influenza scenarios developed collaboratively by the CDC and network members. Results provided by the groups were aggregated into a mean-based ensemble. The ensemble and most component models agreed on the ranking of the most and least effective intervention strategies by impact but not on the magnitude of those impacts. In the scenarios evaluated, vaccination alone, due to the time needed for development, approval, and deployment, would not be expected to substantially reduce the numbers of illnesses, hospitalizations, and deaths that would occur. Only strategies that included early implementation of school closure were found to substantially mitigate early spread and allow time for vaccines to be developed and administered, especially under a highly transmissible pandemic scenario.

Indexed as

Influenza, HumanInfluenza VaccinesAntiviral AgentsHumansPandemicsPharmaceutical PreparationsAntiviral AgentsInfluenza VaccinesPharmaceutical Preparationsepidemiologyinfectious diseaseInfluenzamodellingpandemics

Identifiers

PMID37399393
PMCPMC10334766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.